(Q71182389)
Statements
Safety and immunogenicity of a candidate HIV-1 vaccine in healthy adults: recombinant glycoprotein (rgp) 120. A randomized, double-blind trial. NIAID AIDS Vaccine Evaluation Group (English)
B S Graham
G J Gorse
K Weinhold
M C Keefer
D H Schwartz
T J Matthews
J R Esterlitz
F Sinangil